A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/565 (2006.01) A61K 9/00 (2006.01) A61K 9/70 (2006.01) A61K 31/567 (2006.01) A61K 31/57 (2006.01) A61P 15/18 (2006.01)
Patent
CA 2478336
A method of contraception is described comprising the step of administering to a menstruating female a cycle of contraceptive therapy, said cycle of therapy including, for at least 42 successive days, the administration of a combination of an estrogen and a progestogen in a contraceptively effective daily dosage wherein said progestogen is a potent sulfatase inhibiting progestogen and said cycle of therapy including 4-8 days which are free of estrogen administration following said at least 42 successive days.
La présente invention concerne une méthode de contraception consistant à administrer à une femelle menstruée, un cycle de traitement contraceptif, ledit cycle de traitement comprenant, pendant au moins 42 jours successifs, l'administration d'une combinaison d'un oestrogène et d'un progestagène selon une posologie quotidienne efficace d'un point de vue contraceptif, ledit progestagène étant un progestagène inhibiteur de sulfatase puissant et ledit cycle de traitement comprenant 4 à 8 jours sans administration d'oestrogènes suivant lesdits au moins 42 jours successifs.
Caubel Patrick Michel
Friedman Andrew Joseph
Janssen Pharmaceutica N.v.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Extended cycle estrogen and sulfatase inhibiting progestogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended cycle estrogen and sulfatase inhibiting progestogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended cycle estrogen and sulfatase inhibiting progestogen... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1921335